Ameritas Investment Partners, Inc. Sangamo Therapeutics, Inc Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $13,457 - $20,040	1,538 Added 18.61%	9,803 $106,000
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $16,652 - $23,720	1,198 Added 16.95%	8,265 $117,000
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $15,207 - $22,745	1,311 Added 22.78%	7,067 $116,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,756	5,756 $51,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.